𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic apheresis in hematological and oncological diseases

✍ Scribed by Kathleen M. Grima

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
148 KB
Volume
15
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic apheresis in renal and metab
Therapeutic apheresis in renal and metabolic diseases
✍ Jeffrey L. Winters; Alvaro A. Pineda; Bruce C. McLeod; Kathleen M. Grima πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 1 views
An overview of therapeutic apheresis in
An overview of therapeutic apheresis in pediatrics
✍ Dolores M. Galacki πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 22 KB πŸ‘ 1 views

Therapeutic apheresis in pediatrics requires selected modifications due to the child's smaller size, blood volume, and developmental age. Red blood cell priming is used to prevent dilution of the child's hematocrit from the normal saline prime. Continuous flow cell separators maintain isovolemia. Di

Phytanic acid storage disease (Refsum's
Phytanic acid storage disease (Refsum's disease): Clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management
✍ Robert Weinstein πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 26 KB πŸ‘ 1 views

Phytanic acid storage disease (known also as Refsum's Disease) is caused by inherited defects in the metabolic pathway for phytanic acid, a dietary branched-chain fatty acid. Poorly metabolized phytanic acid accumulates in fatty tissues, including myelin sheaths, and in organs including the liver an